Jefferies Financial Group Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its price objective lifted by equities research analysts at Jefferies Financial Group from $475.00 to $575.00 in a research note issued on Monday. Jefferies Financial Group's price objective suggests a potential upside of 0.27% from the stock's previous close.

A number of other equities analysts also recently issued reports on the stock. Mizuho lifted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday. Bernstein Bank lifted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research report on Monday. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday. Finally, Stifel Nicolaus lifted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $613.10.

Intuitive Surgical Price Performance

Shares of ISRG stock traded down $10.57 during trading hours on Monday, reaching $573.48. The company had a trading volume of 2,439,723 shares, compared to its average volume of 2,025,429. The company has a market cap of $204.26 billion, a price-to-earnings ratio of 92.20, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. Intuitive Surgical has a 12 month low of $364.17 and a 12 month high of $616.00. The business has a fifty day simple moving average of $547.16 and a 200-day simple moving average of $505.21.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the firm's stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares of the company's stock, valued at approximately $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 42,453 shares of company stock valued at $22,059,506 in the last quarter. 0.90% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $26,000. Godsey & Gibb Inc. boosted its stake in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $38,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.